CytoSorbents Analyst Ratings
CytoSorbents Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2023 | 67.36% | B. Riley Securities | → $4 | Reinstates | Buy → Buy |
| 08/02/2023 | 130.13% | HC Wainwright & Co. | → $5.5 | Reiterates | Buy → Buy |
| 05/03/2023 | 130.13% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
| 03/10/2023 | 130.13% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
| 11/04/2022 | 130.13% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 05/04/2022 | 151.05% | B. Riley Securities | $7 → $6 | Maintains | Buy |
| 05/04/2022 | 276.57% | HC Wainwright & Co. | $13 → $9 | Maintains | Buy |
| 09/17/2020 | 527.62% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 09/01/2020 | 527.62% | SVB Leerink | → $15 | Initiates Coverage On | → Outperform |
| 05/06/2020 | 569.46% | B. Riley Securities | $12 → $16 | Maintains | Buy |
| 05/06/2020 | 485.77% | HC Wainwright & Co. | $13 → $14 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/07/2023 | 67.36% | B.萊利證券 | →$4 | 恢復 | 購買→購買 |
| 08/02/2023 | 130.13% | HC Wainwright公司 | →$5.5 | 重申 | 購買→購買 |
| 05/03/2023 | 130.13% | HC Wainwright公司 | →$5.5 | 重申 | →購買 |
| 03/10/2023 | 130.13% | HC Wainwright公司 | →$5.5 | 重申 | →購買 |
| 11/04/2022 | 130.13% | HC Wainwright公司 | $9→$5.5 | 維護 | 買 |
| 05/04/2022 | 151.05% | B.萊利證券 | $7→$6 | 維護 | 買 |
| 05/04/2022 | 276.57% | HC Wainwright公司 | $13→$9 | 維護 | 買 |
| 09/17/2020 | 527.62% | 傑富瑞 | →$15 | 開始承保 | →購買 |
| 09/01/2020 | 527.62% | SVB Leerink | →$15 | 開始承保 | →跑贏大盤 |
| 05/06/2020 | 569.46% | B.萊利證券 | $12→$16 | 維護 | 買 |
| 05/06/2020 | 485.77% | HC Wainwright公司 | $13→$14 | 維護 | 買 |
What is the target price for CytoSorbents (CTSO)?
CytoSorbents(CTSO)的目標價是多少？
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by B. Riley Securities on September 7, 2023. The analyst firm set a price target for $4.00 expecting CTSO to rise to within 12 months (a possible 67.36% upside). 5 analyst firms have reported ratings in the last year.
B·萊利證券於2023年9月7日報道了CytoSorbents(納斯達克：CTSO)的最新目標價。這家分析公司將目標價定為4.00美元，預計CTSO將在12個月內上漲至67.36%。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for CytoSorbents (CTSO)?
對CytoSorbents(CTSO)的最新分析師評級是多少？
The latest analyst rating for CytoSorbents (NASDAQ: CTSO) was provided by B. Riley Securities, and CytoSorbents their buy rating.
分析師對CytoSorbents(納斯達克代碼：CTSO)的最新評級由B.萊利證券提供，CytoSorbents的評級為買入。
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
CytoSorbents(CTSO)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查看公開的財務報表，與CytoSorbents的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。CytoSorbents的上一次評級是在2023年9月7日提交的，所以你應該預計下一次評級將在2024年9月7日左右的某個時候公佈。
Is the Analyst Rating CytoSorbents (CTSO) correct?
分析師對CytoSorbents(CTSO)的評級正確嗎？
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a with a price target of $0.00 to $4.00. The current price CytoSorbents (CTSO) is trading at is $2.39, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的CytoSorbents(CTSO)評級為A，目標價在0.00美元至4.00美元之間。目前CytoSorbents(CTSO)的交易價格為2.39美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。